ES472053A1 - Procedimiento para la preparacion de un agente diagnostico para la determinacion inmunologica de la glucoproteina 3,1s-a2 rica en leucina - Google Patents

Procedimiento para la preparacion de un agente diagnostico para la determinacion inmunologica de la glucoproteina 3,1s-a2 rica en leucina

Info

Publication number
ES472053A1
ES472053A1 ES472053A ES472053A ES472053A1 ES 472053 A1 ES472053 A1 ES 472053A1 ES 472053 A ES472053 A ES 472053A ES 472053 A ES472053 A ES 472053A ES 472053 A1 ES472053 A1 ES 472053A1
Authority
ES
Spain
Prior art keywords
leucine
preparation
glycoprotein
glucoprotein
rich
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES472053A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES472053A1 publication Critical patent/ES472053A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/822Identified hapten
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Procedimiento para la preparación de un agente diagnóstico para la determinación inmunológica de la glucoproteína 3,1 S-alfa2 rica en leucina, caracterizado porque la glucoproteína 3,1 S-alfa2 rica en leucina se administra por vía parenteral a animales vertebrados, eventualmente con adición de un coadyuvante, se extrae ésta después de la formación de anticuerpos en la sangre de los animales, se separa el suero y se extrae la fracción rica en anticuerpos.
ES472053A 1977-04-25 1978-07-26 Procedimiento para la preparacion de un agente diagnostico para la determinacion inmunologica de la glucoproteina 3,1s-a2 rica en leucina Expired ES472053A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2718325A DE2718325C2 (de) 1977-04-25 1977-04-25 Leucinreiches 3,1-S-α↓2↓-Glykoprotein sowie dessen Verwendung

Publications (1)

Publication Number Publication Date
ES472053A1 true ES472053A1 (es) 1979-02-01

Family

ID=6007197

Family Applications (2)

Application Number Title Priority Date Filing Date
ES78468931A Expired ES468931A1 (es) 1977-04-25 1978-04-19 Procedimiento para la preparacion de una glucoproteina de suero humano.
ES472053A Expired ES472053A1 (es) 1977-04-25 1978-07-26 Procedimiento para la preparacion de un agente diagnostico para la determinacion inmunologica de la glucoproteina 3,1s-a2 rica en leucina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES78468931A Expired ES468931A1 (es) 1977-04-25 1978-04-19 Procedimiento para la preparacion de una glucoproteina de suero humano.

Country Status (19)

Country Link
US (1) US4309339A (es)
JP (1) JPS53133619A (es)
AT (1) AT364857B (es)
AU (1) AU519645B2 (es)
BE (1) BE866365A (es)
CA (1) CA1108534A (es)
CH (1) CH643860A5 (es)
DE (1) DE2718325C2 (es)
DK (1) DK176578A (es)
ES (2) ES468931A1 (es)
FR (1) FR2388824A1 (es)
GB (1) GB1599435A (es)
IE (1) IE46735B1 (es)
IT (1) IT1094921B (es)
LU (1) LU79490A1 (es)
NL (1) NL7804361A (es)
NZ (1) NZ187055A (es)
SE (1) SE7804714L (es)
ZA (1) ZA782329B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
DE3410694A1 (de) * 1984-03-23 1985-10-03 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)2(pfeil abwaerts)(pfeil abwaerts)1(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
JPS61294366A (ja) * 1985-06-24 1986-12-25 Toubishi Yakuhin Kogyo Kk 糖鎖に特異的な抗体の検出用試薬及びその使用
CH671879A5 (es) * 1987-02-26 1989-10-13 Nestle Sa
US5101018A (en) * 1989-06-12 1992-03-31 International Minerals & Chemical Corp. Method for recovering recombinant proteins
US5047511A (en) * 1989-08-28 1991-09-10 Pitman-Moore, Inc. Method for recovering recombinant proteins
WO2020075692A1 (ja) * 2018-10-09 2020-04-16 積水メディカル株式会社 ロイシンリッチα2グリコプロテイン組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191533A (en) * 1971-09-29 1980-03-04 Behringwerke Aktiengesellschaft Pregnancy-specific β1 -glycoprotein and process for isolating it
DE2221261A1 (de) * 1972-04-29 1973-11-15 Behringwerke Ag Ap-glykoproteine und verfahren zu ihrer isolierung
FR2222083B1 (es) * 1973-03-22 1976-05-14 Fontaine Michel
DE2640387C3 (de) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Gewebespezifisches Protein und Verfahren zu dessen Herstellung
DE2720704C2 (de) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
ZA782329B (en) 1979-04-25
LU79490A1 (de) 1978-11-28
DK176578A (da) 1978-10-26
IE780801L (en) 1978-10-25
JPS53133619A (en) 1978-11-21
IT1094921B (it) 1985-08-10
BE866365A (fr) 1978-10-25
AU519645B2 (en) 1981-12-17
NL7804361A (nl) 1978-10-27
CH643860A5 (de) 1984-06-29
IT7822620A0 (it) 1978-04-21
NZ187055A (en) 1981-05-29
AT364857B (de) 1981-11-25
DE2718325C2 (de) 1986-09-25
IE46735B1 (en) 1983-09-07
CA1108534A (en) 1981-09-08
SE7804714L (sv) 1978-10-26
ES468931A1 (es) 1978-12-16
ATA292478A (de) 1981-04-15
FR2388824A1 (fr) 1978-11-24
FR2388824B1 (es) 1984-05-18
DE2718325A1 (de) 1978-10-26
US4309339A (en) 1982-01-05
AU3540578A (en) 1979-11-01
GB1599435A (en) 1981-10-07

Similar Documents

Publication Publication Date Title
Pearson et al. A 70000-molecular-weight protein isolated from purified pig gastric mucus glycoprotein by reduction of disulphide bridges and its implication in the polymeric structure
Kishimoto et al. A human salivary protein which promotes adhesion of Streptococcus mutans serotype c strains to hydroxyapatite
KR900013979A (ko) 사람 유두종비루스형 16의 e7 단백질상의 면역원성 영역
Cone et al. Isolation of membrane associated immunoglobulins from T lymphocytes by non-ionic detergents
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
ES470653A1 (es) Procedimiento para el enriquecimiento de una glicoproteina
SE7710808L (sv) Forfarande for undersokning av okoagulerat blod
ES472053A1 (es) Procedimiento para la preparacion de un agente diagnostico para la determinacion inmunologica de la glucoproteina 3,1s-a2 rica en leucina
AU567747B2 (en) Early detection of mammalian pregnancy
DE69131579D1 (de) Synthetisches antigen einer alternden zelle
Geller et al. Electrophoresis of saliva
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
Natori et al. A mouse plasma substance carrying β2‐microglobulin activity and lacking in H‐2 alloantigenic activity
SE7704359L (sv) Forfarande for anrikning av ett placentaspecifikt glykoprotein
ES468932A1 (es) Procedimiento para la preparacion de una proteina.
Stevens et al. Immunochemical and electrophoretic properties of oestrous rabbit uterine fluid proteins obtained by uterine ligation
Stylos et al. Splitting of human thyroglobulin. II. Enzymatic digestion
Campbell et al. Molecular weight and subunits of the alkaline phosphatase of Bacillus licheniformis
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
Stewart-Tull et al. The affinity of a mycobacterial glycopeptide for guinea-pig gamma-globulin
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
AU1994788A (en) Method for the diagnosis of infections with detection of lipopolysaccharide antigens
* Verpoorte, JA,* Joubert, FJ &** Jansen Studies on the soluble antigen and haemolysin of Clostridium chauvoei strain 64
Lonergan et al. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971103